凯象平台|器审中心比对疫情下中美医疗器械应急监管的异同点( 三 )


参考文献:
[1]贾群林,陈莉.美国应急管理体制发展现状及特点[J].中国应急管理,2019(08):62-64.
[2]MedicalCountermeasuresInitiative(MCMi)
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/medical-countermeasures-initiative-mcmi
[3]medicalcountermeasures
https://www.fda.gov/emergency-preparedness-and-response/about-mcmi/what-are-medical-countermeasures
[4]Guidance:EmergencyUseAuthorizationofMedicalProductsandRelatedAuthorities.
https://www.fda.gov/media/97321/download)
[5]SummaryofProcessforEUAIssuance.
https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/summary-process-eua-issuance
[6]PolicyforDiagnosticsTestinginLaboratoriesCertifiedtoPerformHigh-ComplexityTestingunderCLIApriortoEmergencyUseAuthorizationforCoronavirusDisease-2019duringthePublicHealthEmergency.
https://www.fda.gov/media/135659/download
[7]PolicyforCoronavirusDisease-2019TestsDuringthePublicHealthEmergency(Revised).
https://www.fda.gov/media/135659/download
审评六部王佩荣解怡
本文来源于网络 , 由凯象平台整理发布 , 如侵权请联系删除 。 更多医疗器械行业资讯 , 请关注我们的公众号:凯象 。 凯象寻源平台上线啦!您只需通过点击我们的公众号“凯象”的“寻源平台”中的“进入平台”按钮 , 即可进入凯象寻源平台 。 凯象寻源平台将为供需双方打破空间上的壁垒 , 建立一座相互沟通的桥梁 。


推荐阅读